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Sirs,
A number of studies have suggested that 
thyroid disorders, including Hashimoto 
thyroiditis (HT), are more frequent in SLE 
than in general population, with a reported 
prevalence ranging from 3.9 to 24% (1, 2). 
Since a genetic background has been de-
scribed for systemic autoimmune diseases 
as well as for autoimmune thyroid dis-
eases (AITD), and familial aggregation of 
systemic autoimmune diseases and AITD 
has been described (3-6), we have hypoth-
esized that first and second degree relatives 
of systemic lupus erythematosus (SLE) pa-
tients with HT might have an increased risk 
of developing this condition.
The clinical charts of patients with SLE 
were examined, to identify which subjects 
suffered from HT, based on the presence of 
positive thyroid antibodies and ultrasound 
assessment suggestive of an inflammatory 
disease.
Patients were asked about the presence of 
thyroid disorders in their first- and second-
degree relatives, using a structured ques-
tionnaire, designed ad hoc for this study 
(Appendix).
We considered valid the presence of HT 
when the patient reported specifically that 
diagnosis. 
The clinical charts of 401 SLE patients 
(371 female, 30 male) were examined. Six-
ty-eight (17%), 65 women and 3 men had a 
diagnosis of HT, 12 were lost to follow-up. 
Of the remaining 56, 28 (50%) had at least 
one first- or second-degree relative with a 
thyroid disease. A total of 36 relatives (30 
women, 6 men) with a thyroid dysfunction 
were observed. Eight were affected by HT, 
8 by MNG, while the diagnosis was un-
clear in 20 relatives, with 19 cases (53% 
of the total number of relatives) with hypo-
thyroidism and 1 case of hyperthyroidism. 
Two relatives were reported to have had a 
history of papillary carcinoma.
Hashimoto thyroiditis is a common cause 
of hypothyroidism, with a reported preva-
lence of 1-4% in the general population (6, 
7).
A familial aggregation of autoimmune thy-
roiditis has been described and the positivi-
ty of anti-TPO antibodies has been reported 
in 27-34% of the relatives of patients with 
autoimmune thyroiditis. In addition a pa-
rental history of hypo or hyperthyroidism 
has been reported in about 20% of mothers 
of subjects with HT (6).
Various studies have shown an increased 
prevalence of HT in first and second degree 
relatives of SLE patients (3,4); aim of the 
present study was to test the hypothesis as 
to whether relatives of patients with SLE 
and HT could be at increased risk of devel-
oping HT and should therefore be screened 
for such condition.
A diagnosis of HT was reported in 22% of 
first and second-degree relatives of SLE 
patients with HT. However, these data may 
underestimate the real prevalence of HT as 
it could be reasonable to consider the ge-
neric hypothyroidism reported in 20 rela-
tives as possible cases of HT. 
Secondly, relatives were not re-evaluated 
and this could determine an additional 
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underestimation of the real prevalence of 
thyroid disorders in the families of SLE pa-
tients with HT.
To our knowledge this is the first study as-
sessing the risk of HT among relatives of 
SLE patients with HT. Based on these re-
sults, it might be interesting to perform ad-
ditional studies on larger populations, with 
a direct evaluation of relatives; this could 
help in further clarifying if relatives of SLE 
patients with HT should be counseled to 
evaluate the presence of autoimmune thy-
roid diseases.
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